Increase in gonococcal arthritis in Madrid, Spain, 2022-2023

Int J STD AIDS. 2024 Sep;35(10):831-835. doi: 10.1177/09564624241254877. Epub 2024 May 15.

Abstract

In recent years, there has been an increase in Neisseria gonorrhoeae infections in Europe and Spain. Disseminated gonococcal infection is an uncommon clinical presentation that includes gonococcal arthritis. Improved antibiotic treatment has reduced the incidence of gonococcal arthritis. However, the increase in gonococcal infections may have increased the frequency of this clinical entity in recent times. We report five cases of gonococcal arthritis in patients in a tertiary-care hospital in the northern area of Madrid (Spain) from October 2022 to October 2023. Major cases occurred in male patients with unprotected sex and polyarticular symptoms requiring hospital admission and treatment with ceftriaxone and cefixime. The use of molecular techniques has allowed the detection of a greater number of culture-negative cases of gonococcal arthritis, as well as the detection of mutations associated with resistance to fluoroquinolone for switching to oral treatment.

Keywords: Neisseria gonorrhoeae; fluoroquinolones; gonococcal arthritis; macrolides; sexually transmitted infections; synovial fluid.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents* / therapeutic use
  • Arthritis, Infectious* / diagnosis
  • Arthritis, Infectious* / drug therapy
  • Arthritis, Infectious* / epidemiology
  • Arthritis, Infectious* / microbiology
  • Cefixime / therapeutic use
  • Ceftriaxone* / therapeutic use
  • Drug Resistance, Bacterial
  • Gonorrhea* / diagnosis
  • Gonorrhea* / drug therapy
  • Gonorrhea* / epidemiology
  • Gonorrhea* / microbiology
  • Humans
  • Neisseria gonorrhoeae* / drug effects
  • Neisseria gonorrhoeae* / genetics
  • Neisseria gonorrhoeae* / isolation & purification
  • Spain / epidemiology
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Cefixime
  • Ceftriaxone